ANTHRACYCLINE ENCAPSULATED WITH POLYSACCHARIDE FOR USE IN THE TREATMENT OF TUMOURS

The invention relates to a new form of a drug in the form of anthracycline encapsulated with a polysaccharide selected from epirubicin, daunorubicin, doxorubicin, idarubicin, especially encapsulated with dextran, for use in the treatment of specific tumours. L'invention concerne une nouvelle fo...

Full description

Saved in:
Bibliographic Details
Main Authors ŻERO, Paweł, CIACH, Tomasz, PIETRZAK, Piotr, PIETRAS, Joanna, MAŁKOWSKA, Justyna, ADAMSKA, Kinga, KOŚNIK, Wioletta, ŻUK, Paweł, CHROMIŃSKI, Mikołaj, KICIAK, Adam, KULIKOWSKA-DARŁAK, Aleksandra, SOBIECKA, Agnieszka, WASIAK, Iga
Format Patent
LanguageEnglish
French
Published 12.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to a new form of a drug in the form of anthracycline encapsulated with a polysaccharide selected from epirubicin, daunorubicin, doxorubicin, idarubicin, especially encapsulated with dextran, for use in the treatment of specific tumours. L'invention concerne une nouvelle forme d'un médicament sous la forme d'une anthracycline encapsulée avec un polysaccharide choisi parmi l'épirubicine, la daunorubicine, la doxorubicine, l'idarubicine, en particulier encapsulée avec du dextrane, destinée à être utilisée dans le traitement de tumeurs spécifiques.
Bibliography:Application Number: WO2019PL50014